Keywords
High-risk pregnancy
Infectious complications in pregnancy
Premature delivery
Amapá
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To identify the clinical and epidemiological characteristics of pregnant women diagnosed with COVID-19 in a municipality in the state of Amapá. Methods: This was a retrospective descriptive study. The sample consisted of 18 pregnant women with COVID-19 seen at the University Hospital of Amapá between June and December 2020. Data was collected from medical records, analyzing sociodemographic variables, signs and symptoms of covid-19, type of delivery, admission to the Intensive Care Unit and maternal and neonatal outcome. Results: The average age of the pregnant women was 25.2 years, the majority were brown, had completed high school and were housewives. The most common comorbidities were systemic arterial hypertension and obesity. The most common maternal complications were pre-eclampsia and eclampsia, and almost half of the pregnant women required the Intensive Care Unit (ICU). Three maternal deaths were recorded. Conclusion: Pregnant women with comorbidities in the third trimester of pregnancy presented respiratory distress requiring intensive care and unfavorable outcomes.
References
AFSHAR Y, et al. Clinical presentation of coronavirus disease 2019 (COVID-19) in pregnant and recently pregnant people. Obstetrics and gynecology, 2020; 136(6): 1117.
AMAPÁ. Governo do Estado do Amapá. 2020. Termo de cessão de uso de espaço físico que entre si celebram a Universidade Federal do Amapá e o Governo do Estado do Amapá, de 08 de maio de 2020. Disponível em: http://www.unifap.br/wp-content/uploads/2020/05/NEPCREAP_008319.pdf. Acessado em: 08 de abril de 2023.
ANDREAS NJ, et al. Human breast milk: A review on its composition and bioactivity. Early human development, 2015; 91(11): 629-635.
BADR DA, et al. Severe acute respiratory syndrome coronavirus 2 and pregnancy outcomes according to gestational age at time of infection. Emerging infectious diseases, 2021; 27(10): 2535-2543.
BARBOSA FILHO MC, et al. Síndrome respiratória aguda grave por COVID-19: perfil epidemiológico em gestantes e puérperas no Amazonas. Medicina (Ribeirão Preto), 2022; 55(2).
CIRELLI JF, et al. The Burden of Indirect Causes of Maternal Morbidity and Mortality in the Processof Obstetric Transition: A Cross-Sectional Multicenter Study. International Journal of Gynecology & Obstetrics, 2018; 40: 106-114.
DASHRAATH P, et al. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. American journal of obstetrics and gynecology, 2020; 222(6): 521-531.
DONZELLI M, et al. Prone positioning and convalescent plasma therapy in a critically ill pregnant woman with COVID‐19. Clinical case reports, 2020; 8(12): 3351-3357.
FIOCRUZ, 2020. Monitoramento de casos de síndrome respiratória aguda grave (SRAG) notificados no SIVEP-Gripe. Disponível em: http://info.gripe.fiocruz.br/. Acessado em: 7 de maio de 2020.
GORBALENYA AE, et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology, 2020; 5(4): 536–544.
GROULX T, et al. Prenatal care disruptions and associations with maternal mental health during the COVID-19 pandemic. Frontiers in Global Women's Health, 2021; 2: 648428.
HALSCOTT T, et al. Society for maternal-fetal medicine management considerations for pregnant patients with COVID-19. SFMF Guideline, 2020: 2021: 7-26.
HUAMAN YR, et al. Clinical characteristics and sociodemographic factors associated with COVID-19 infection in pregnant women in a maternal and children's public hospital. Medwave, 2021; e8442-e8442.
ISAAC B, et al. Maternal and Fetal Outcome in Pregnant Women With Critical COVID-19 Treated With Tocilizumab in a Tertiary Care Hospital in Dubai. Cureus, 2023; 15(1).
KHAN MMA, et al. COVID-19 infection during pregnancy: a systematic review to summarize possible symptoms, treatments, and pregnancy outcomes. MedRxiv, 2020; 03(31): 20049304.
MASUD SB, et al. Adverse birth outcomes among pregnant women with and without COVID-19: A comparative study from Bangladesh. Journal of preventive medicine and public health, 2021; 54(6): 422.
MENDONÇA CV, et al. Olfactory dysfunction in COVID-19: a marker of good prognosis? Brazilian Journal of Otorhinolaryngology, 2022; 88: 439-444.
MENDOZA M, et al. Pre-eclampsia-like syndrome induced by severe COVID-19: a prospective observational study. An International Journal of Obstetrics and Gynaecology, 2020; 127(11): 1374-1380.
ORELLANA JDY, et al. Excess deaths during the COVID-19 pandemic: underreporting and regional inequalities in Brazil. Cad. Saúde Pública (Online), 2021; e00259120-e00259120.
PRADO MFD, et al. Análise da subnotificação de COVID-19 no Brasil. Revista Brasileira de Terapia Intensiva, 2020; 32: 224-228.
QEADAN F, et al. The risk of clinical complications and death among pregnant women with COVID-19 in the Cerner COVID-19 cohort: a retrospective analysis. BMC pregnancy and childbirth, 2021; 21: 1-14.
SAN-JUAN R, et al. Incidence and clinical profiles of COVID-19 pneumonia in pregnant women: A single-centre cohort study from Spain. EClinical Medicine, 2020; 23: 100407.
SERRA FE, et al. COVID-19 outcomes in hospitalized puerperal, pregnant, and neither pregnant nor puerperal women. PLoS One, 2021; 16(11): e0259911.
SHI Y, et al. An overview of COVID-19. Journal of Zhejiang University. Science. B, 2020; 1.
SONG F, et al. Emerging 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology, 2020; 295(1): 210-217.
VIVANTI AJ, et al. Retrospective description of pregnant women infected with severe acute respiratory syndrome coronavirus 2, France. Emerging Infectious Diseases, 2020; 26(9): 2069.
WENG LM, et al. Pain symptoms in patients with coronavirus disease (COVID-19): A literature review. Journal of Pain Research, 2021; 147-159.
WONG YP, et al. The effects of COVID-19 on placenta and pregnancy: what do we know so far? Diagnostics, 2021; 11(1): 94.
YAN J, et al. Coronavirus disease 2019 in pregnant women: a report based on 116 cases. American journal of obstetrics and gynecology, 2020; 223(1): 111. e1-111. e14.
YANG R, et al. Pregnant women with COVID-19 and risk of adverse birth outcomes and maternal-fetal vertical transmission: a population-based cohort study in Wuhan, China. BMC medicine, 2020; 18(1): 1-7.
ZOLDAN C, et al. Clinical course of pregnant women with SARS-CoV-2 infection with development of COVID-19: na integrative literature review. Research, Society and Development, 2021; 10(13).